Traditionally genetics has focused on direct associations between genotypes and phenotypes within individuals. This logical focus on principles of Mendelian genetics has led to a revolution in our understanding of fundamental biological processes and disease genetics. However, observations such as 'missing heritability'in genome-wide association studies suggest that our explanations for phenotypic variation and disease risk are incomplete in important ways. In addition, several recent reports of interacting genes in different generations and transgenerational genetic effects strongly suggest that alternative modes of inheritance exist. These reports involve a wide variety of embryonic and adult traits and can lead to dysfunctions and diseases such as embryonic lethality, cancer, obesity and anxiety. Attributing phenotypes to gene action in previous generations is a fundamental and profound observation that suggests that both epigenetic (non-DNA) and genetic (DNA) mechanisms guide inheritance. Our discoveries implicate RNA editing, miRNA biology, translation control as well as perhaps RNA granules in these transgenerational effects. Proposed work will identify the molecular basis for transgenerational effects and characterize the mechanisms for epigenetics across generations. My accomplishments in comparative genomics, the developmental biology of neural tube defects and testicular cancer, the physiological genetics of obesity and metabolic diseases, and the genetic architecture of complex traits demonstrate my ability to identify hard problems and make important contributions in an unusually wide variety of biomedical fields. The proposed work on transgenerational genetic effects represents a new and exciting area of research, partly because it involves questions and technologies that I am eager to learn, but more importantly because the results could revolutionize our understanding of the molecular mechanisms of inheritance as well as assessment of phenotyp

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
1DP1OD006911-01
Application #
7979938
Study Section
Special Emphasis Panel (ZGM1-NDPA-B (01))
Program Officer
Jones, Warren
Project Start
2010-09-30
Project End
2015-07-31
Budget Start
2010-09-30
Budget End
2011-07-31
Support Year
1
Fiscal Year
2010
Total Cost
$848,000
Indirect Cost
Name
Institute for Systems Biology
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98109
Cannon, Matthew V; Buchner, David A; Hester, James et al. (2014) Maternal nutrition induces pervasive gene expression changes but no detectable DNA methylation differences in the liver of adult offspring. PLoS One 9:e90335
Xie, Fang; von Dadelszen, Peter; Nadeau, Joseph (2014) CMV infection, TLR-2 and -4 expression, and cytokine profiles in early-onset preeclampsia with HELLP syndrome. Am J Reprod Immunol 71:379-86
Blanc, Valerie; Park, Eddie; Schaefer, Sabine et al. (2014) Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver. Genome Biol 15:R79
Nelson, Vicki R; Heaney, Jason D; Tesar, Paul J et al. (2012) Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability. Proc Natl Acad Sci U S A 109:E2766-73
Cowley Jr, Allen W; Nadeau, Joseph H; Baccarelli, Andrea et al. (2012) Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension 59:899-905
Nelson, Vicki R; Spiezio, Sabrina H; Nadeau, Joseph H (2010) Transgenerational genetic effects of the paternal Y chromosome on daughters' phenotypes. Epigenomics 2:513-21
Nelson, Vicki R; Nadeau, Joseph H (2010) Transgenerational genetic effects. Epigenomics 2:797-806